Charlene
Charlene Barnes-Kahoe US
Patent application number | Description | Published |
---|---|---|
20150041155 | ELECTROMAGNETIC OIL PIPE PLUGGER - An electromagnetic chemical adhesive pipe plugging system is provided, including an elongated hollow injection quill, said quill having a plurality of circumferentially spaced magnetic jaws, a plurality of circumferentially spaced shoes, and a plurality of circumferentially spaced magnetic heads, wherein the magnetic jaws, shoes, and magnetic heads are capable of being pushed radially outward into gripping engagement with the inner diameter of a pipe assisted by chemical adhesive bonds against the pressure forces acting thereon, and the magnetic heads are capable of creating an intense magnetic field. Methods and means of deploying, positioning, maintaining, controlling, and operating the system are also provided and include insertion through the BOP primary exit line or choke and kill lines within a BOP device. | 02-12-2015 |
Charlene Barroga, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110243853 | MODELS OF ERYTHROPOIESIS - Non human animal models are provided for diseases involving erythroid function, particularly myeloproliferative disease. The models are useful for testing and screening of biologically active agents that affect erythropoiesis, and erythroid function. In the animal models of the invention, a hematopoietic stem or progenitor cell (HSC) population that has been genetically altered by the introduction of a mutant JAK2 coding sequence is transplanted into an immunocompromised, xenogeneic, non-human recipient. The recipient animal is engrafted with the cell population at a high frequency, and develops a myeloproliferative disorder characterized by polycythemia. | 10-06-2011 |
Charlene Bush-Donovan, Livermore, CA US
Patent application number | Description | Published |
---|---|---|
20100041019 | Methods of Screening for Respiratory Synctial Virus and Human Metapneumovirus - Provided are nucleic acid primers and probes for use in diagnostic assays to screen for respiratory infections, such as respiratory syncytial virus (“RSV”) and human metapneumovirus (hMPV). The primers and probes may be used to screen for RSV or hMPV in a singleplex assay or they may be used in a multiplex assay to simultaneously screen for RSV and hMPV, or RSV and/or hMPV and any of the following viruses: influenza A, and influenza B, parainfluenza viruses, adenovirus, coronavirus, and rhinoviruses. | 02-18-2010 |
20100047800 | Reagents and Methods for Detecting CYP2C9 Polymorphisms - The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the specific detection of clinically relevant CYP2C9 polymorphisms, in particular CYP2C9 polymorphisms associated with adverse drug response. The oligonucleotide sequences are also provided assembled as kits that can be used to predict how an individual will respond to drugs or other xenobiotic compounds that are metabolized, at least in part, by CYP2C9. | 02-25-2010 |
20100105041 | REAGENTS AND METHODS FOR DETECTING CYP2D6 POLYMORPHISMS - The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the specific detection of clinically relevant CYP2D6 polymorphisms, in particular CYP2D6 polymorphisms associated with adverse drug response. The oligonucleotide sequences are also provided assembled as kits that can be used to predict how an individual will respond to drugs or other xenobiotic compounds that are metabolized, at least in part, by CYP2D6. | 04-29-2010 |
20100248220 | Chlamydia Trachomatis Specific Oligonucleotide Sequences - The present invention relates to oligonucleotide sequences for amplification primers and detection probes and to their use in nucleic acid amplification methods for the selective and specific detection of | 09-30-2010 |
20100255482 | Hepatitis B Virus (HBV) Specific Oligonucleotide Sequences - The present invention relates to oligonucleotide sequences for amplification primers and detection probes and to their use in nucleic acid amplification methods for the detection of HBV in biological samples. In particular, oligonucleotide sequences are provided for the sensitive qualitative or quantitative detection of all eight HBV genotypes. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the diagnosis of HBV infection. | 10-07-2010 |
20100330548 | Nucleic Acid Primers and Probes for Detecting Human and Avian Influenza Viruses - Provided are nucleic acid sequences that are used to prepare primers and probes that are used in a kinetic polymerase chain reaction (kPCR) assay to detect influenza viruses in a human or animal subject. The starting material for the kPCR assays may be DNA or RNA and the assays may be conducted in a singleplex assay to detect a single influenza virus or in a multiplex assay to detect multiple influenza viruses. The primers and probes have utility in the detection and quantification of type A and type B influenza viruses (INFA and INFB, respectively) and have been shown to be effective for the detection and quantification of all the known INFA subtypes, namely, H1, H2, H3, H4, H5, H6, H7, H8, and H9. | 12-30-2010 |
Charlene Chen, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20120136601 | Method and System of Improved Uniformity Testing - A method and system includes a first substrate and a second substrate, each substrate comprising a predetermined baseline transmittance value at a predetermine wavelength of light, processing regions on the first substrate by combinatorially varying at least one of materials, process conditions, unit processes, and process sequences associated with the graphene production, performing a first characterization test on the processed regions on the first substrate to generate first results, processing regions on a second substrate in a combinatorial manner by varying at least one of materials, process conditions, unit processes, and process sequences associated with the graphene production based on the first results of the first characterization test, performing a second characterization test on the processed regions on the second substrate to generate second results, and determining whether at least one of the first substrate and the second substrate meet a predetermined quality threshold based on the second results. | 05-31-2012 |
20130122614 | Method and System of Improved Uniformity Testing - A method and system includes a first substrate and a second substrate, each substrate comprising a predetermined baseline transmittance value at a predetermine wavelength of light, processing regions on the first substrate by combinatorially varying at least one of materials, process conditions, unit processes, and process sequences associated with the graphene production, performing a first characterization test on the processed regions on the first substrate to generate first results, processing regions on a second substrate in a combinatorial manner by varying at least one of materials, process conditions, unit processes, and process sequences associated with the graphene production based on the first results of the first characterization test, performing a second characterization test on the processed regions on the second substrate to generate second results, and determining whether at least one of the first substrate and the second substrate meet a predetermined quality threshold based on the second results. | 05-16-2013 |
20130140512 | NONVOLATILE RESISTIVE MEMORY ELEMENT WITH A PASSIVATED SWITCHING LAYER - A nonvolatile resistive memory element has a novel variable resistance layer that is passivated with non-metallic dopant atoms, such as nitrogen, either during or after deposition of the switching layer. The presence of the non-metallic dopant atoms in the variable resistance layer enables the switching layer to operate with reduced switching current while maintaining improved data retention properties. | 06-06-2013 |
20140055152 | CIRCULAR TRANSMISSION LINE METHODS COMPATIBLE WITH COMBINATORIAL PROCESSING OF SEMICONDUCTORS - Methods and structures are described for determining contact resistivities and Schottky barrier heights for conductors deposited on semiconductor wafers that can be combined with combinatorial processing, allowing thereby numerous processing conditions and materials to be tested concurrently. Methods for using multi-ring as well as single-ring CTLM structures to cancel parasitic resistance are also described, as well as structures and processes for inline monitoring of properties. | 02-27-2014 |
20140103280 | NONVOLATILE RESISTIVE MEMORY ELEMENT WITH A PASSIVATED SWITCHING LAYER - A nonvolatile resistive memory element has a novel variable resistance layer that is passivated with non-metallic dopant atoms, such as nitrogen, either during or after deposition of the switching layer. The presence of the non-metallic dopant atoms in the variable resistance layer enables the switching layer to operate with reduced switching current while maintaining improved data retention properties. | 04-17-2014 |
20140166958 | Controlling ReRam Forming Voltage with Doping - An internal electrical field in a resistive memory element can be formed to reduce the forming voltage. The internal electric field can be formed by incorporating one or more charged layers within the switching dielectric layer of the resistive memory element. The charged layers can include adjacent charge layers to form dipole layers. The charged layers can be formed at or near the interface of the switching dielectric layer with an electrode layer. Further, the charged layer can be oriented with lower valence substitution side towards lower work function electrode, and higher valence substitution side towards higher work function electrode. | 06-19-2014 |
20140264224 | Performance Enhancement of Forming-Free ReRAM Devices Using 3D Nanoparticles - Resistive random access memory (ReRAM) cells can include an embedded metal nanoparticle switching layer and electrodes. The metal nanoparticles can be formed using a micelle solution. The generation of the nanoparticles can be controlled in multiple dimensions to achieve desirable performance characteristics, such as low power consumption as well as low and consistent switching currents. | 09-18-2014 |
20140264321 | Method of Fabricating IGZO by Sputtering in Oxidizing Gas - In some embodiments, oxidants such as ozone (O | 09-18-2014 |
20150064873 | Controlling ReRam Forming Voltage with Doping - An internal electrical field in a resistive memory element can be formed to reduce the forming voltage. The internal electric field can be formed by incorporating one or more charged layers within the switching dielectric layer of the resistive memory element. The charged layers can include adjacent charge layers to form dipole layers. The charged layers can be formed at or near the interface of the switching dielectric layer with an electrode layer. Further, the charged layer can be oriented with lower valence substitution side towards lower work function electrode, and higher valence substitution side towards higher work function electrode. | 03-05-2015 |
20150079727 | Amorphous IGZO Devices and Methods for Forming the Same - Embodiments described herein provide improvements to indium-gallium-zinc oxide devices, such as amorphous IGZO thin film transistors, and methods for forming such devices. A relatively thin a-IGZO channel may be utilized. A plasma treatment chemical precursor passivation may be provided to the front-side a-IGZO interface. High-k dielectric materials may be used in the etch-stop layer at the back-side a-IGZO interface. A barrier layer may be formed above the gate electrode before the gate dielectric layer is deposited. The conventional etch-stop layer, typically formed before the source and drain regions are defined, may be replaced by a pre-passivation layer that is formed after the source and drain regions are defined and may include multiple sub-layers. | 03-19-2015 |
Charlene Chen, Nanjing CN
Patent application number | Description | Published |
---|---|---|
20160083020 | COMPARTMENT PANEL ASSEMBLY AND VEHICLE EMPLOYING THE SAME - The present invention in one or more embodiments provides a compartment panel assembly to be positioned between one or more seats and a trunk storage of a vehicle. The compartment panel includes a panel portion, a protruding portion extending from the panel portion and including a first wall which defines thereupon a first aperture, and a first storage container to be at least partially received through the first aperture. The present invention in one or more embodiments is advantageous positioned in providing effective storage within the vehicle interior, and in particular providing storage spaces that are lockable and/or not directly visible for enhanced storage security. | 03-24-2016 |
Charlene Oesterling, Knoxville, TN US
Patent application number | Description | Published |
---|---|---|
20110077133 | EXERCISE APPARATUS - An exercise apparatus for jumping exercises including at last one handle and an appendage, the apparatus further including a first attachment member including an aperture defining a first zone and a second zone, the second zone shaped similar to a cylinder. The handle includes a hub that fits at least in part within the first zone and can be rapidly engaged within the second zone so to attach the appendage to the handle while allowing rotational movement of the hub within the second zone. | 03-31-2011 |
Charlene Ranadheera, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20120122896 | 2,1,3-BENZOXADIAZOL DERIVATIVES FOR THE INHIBITION OF INFLUENZA A AND B VIRUS AND RESPIRATORY SYNCYTIAL VIRUS REPLICATION - A 2,1,3-benzoxadiazole compound as a medicament according to the invention is one of the following compounds: 4-[(4-methoxybenzyl)thio]-7-nitro-2,1,3-benzoxadiazole, 2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)thio]ethyl 4-methoxybenzene-1-sulfonate, 4-[(4-methylphenyl)thio]-7-nitro-2,1,3-benzoxadiazole, 4-[(2,4-dichlorophenyl)thio]-7-nitro-2,1,3-benzoxadiazole, 2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)thio]ethan-1-ol, 4-[(4-methylbenzyl)thio]-7-nitro-2,1,3-benzoxadiazole, 4-[(4-fluorophenyl)thio]-7-nitro-2,1,3-benzoxadiazole, 4-[(3-chlorophenyl)-thio]-7-nitro-2,1,3-benzoxadiazole, 2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)thio]ethyl-4-methoxy-benzoate, 5-[4-(tert-butyl)-1,3-thiazol-2-yl]-2,1,3-benzoxadiazole, N-benzyl-4-nitro-2,1,3-benzoxadiazol-5-amine, 4-nitro-7-(phenylmethylsulfanyl)-2,1,3-benzoxadiazole, 4-nitro-7-(phenylmethylsulfonyl)-2,1,3-benzoxadiazole, 2-(hydroxymethyl)-5-[6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)sulfanyl]purin-9-yl]oxolane-3,4-diole, or 2-[2-amino-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)sulfanyl]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol; or a physiologically tolerable salt, solvate, or physiologically functional derivative thereof. Said compounds are particularly advantageous for treating and/or preventing influenza type A and/or influenza type B infections in humans, mammals and/or birds, and for treating and/or preventing respiratory syncytial virus infections in humans, mammals and/or birds. | 05-17-2012 |
Charlene Rnadheera, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20120129764 | INFLUENZA A AND B VIRUS REPLICATION-INHIBITING PEPTIDES - A synthesized or isolated influenza virus replication-inhibiting peptide that competitively inhibits protein-protein interaction of the PA and PB1 of both influenza Virus Types A and B and novel in vitro binding screen to identify peptides with antiviral activity against influenza viruses of both type A and B is disclosed. In addition to the well-known pandemic influenza A viruses (such as the 1918 “Spanish” flu or H5N1), both type A and B viruses contribute greatly to the annual recurring epidemics that cause the vast majority of human cases and medical cost. Surprisingly, it was found that the novel virus replication-inhibiting, are able to inhibit protein-protein interaction of the PA and PB1 subunits of the heterotrimeric viral RNA polymerase complex of both influenza virus types A and B. The viral polymerase sub-unit interaction domain turned out as an effective target for the new antivirals, as correct assembly of the three viral polymerase subunits PB1, PB2 and PA is required for viral RNA synthesis and infectivity. | 05-24-2012 |
Charlene Sun, Pleasanton, CA US
Patent application number | Description | Published |
---|---|---|
20150349217 | PROCESS FOR PREPARING A SEMICONDUCTOR STRUCTURE FOR MOUNTING - A process for preparing a semiconductor structure for mounting to a carrier is disclosed. The process involves causing a support material to substantially fill a void defined by surfaces formed in the semiconductor structure and causing the support material to solidify sufficiently to support the semiconductor structure when mounted to the carrier. | 12-03-2015 |